Global equities traded higher with Europe
catching up with the US markets. PMIs
(Purchasing Managers' Index) confirmed
a few features - the global boom is taking
shape; it continues to exceed optimistic
expectations; and Europe is catching up
to the US. Q1 earnings are beating high
expectations in the US and Europe. The
month confirmed two core elements:
that global growth leadership is rotating
from a decelerating China to a booming
US. EM (Emerging Markets) thus lags, but
aside from a China which will slow due to
deliberate policy tightening, others should
lift from midyear due to US/European pull
and domestic vaccine rollout.
Covid & Vaccines:
Daily new cases surged over the month, with last 12 days registering >300,000/day.
Last week of April appeared to be showing first signs of stabilizing around the 350,000/day mark, likely
in response to the proliferation of local restrictions being imposed around the country. However, the last
three days (Apr 30 - May 2) recorded a devastating increase, with new daily cases at 0.4/0.39/0.37million
per day, respectively, as vaccination drive in some states gets hit by shortages of shots.
National positivity rates remain in the alarming 19-21% range. There is, however, rotation within the country
- with states such as Kerala, Karnataka, UP and Tamil Nadu now witnessing increased stress. Yet, the
declines seen in Mumbai (~4,000 from 10,000 two weeks back), Maharashtra (deceleration in pace of
daily new cases) and some stagnation in Delhi recently creates a template and provides hope that the
second wave will rapidly peak in most other parts of India.
Restrictions: 6 states/UT (union territories) accounting for 1/3rd of India's GDP announced stringent
lockdowns and states/UT accounting for half of India's GDP announced weekend lockdowns along with
night curfew. All these led to an across the board fall in mobility to levels last seen in Oct'2020.
Vaccination: The absolute pace of vaccinations has slowed from 3.4 million/day to 2.5 million/day over
the last 10 days; about 9.15% of India's population has received at least one dose. India announced the
next phase of vaccinations wherein all citizens above the age of 18 years would be eligible from May 01,
2021. However, shortage of vaccines meant a delay in implementation. To bridge the gap, government
decided to fast-track approvals of vaccines cleared for use in the US, UK, EU (European Union) and
Japan and allowed states / private players to procure the vaccines (upto 50% of supply) directly from
the manufacturers.
Oxygen Crisis: Rapid increase in Covid cases led to a severe shortage of medical oxygen in the country,
despite all the efforts to divert the supplies from industries to hospitals. Government decided to import
more than ~10,000 oxygen concentrators and sanctioned ~500 new oxygen plants to be set up under PM
Cares Fund.